Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America

Date

2019

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Adis, Springer Healthcare

Abstract

Description

Citaciones: 12

Keywords

Biosimilar, Pharmacovigilance, Latin Americans, Medicine, Quality (philosophy), Risk analysis (engineering), Business

Citation

DOI

10.1007/s40120-019-0139-y

URI

https://doi.org/10.1007/s40120-019-0139-y
 https://andeanlibrary.org/handle/123456789/45912

Collections

Artículo Científico Publicado